Cargando…
Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies
Conventional chemotherapeutics target the proliferating fraction of cells in the patient’s body, which will include the tumor cells, but are also toxic to actively proliferating normal tissues. Cellular stresses, such as those imposed by chemotherapeutic drugs, induce cell cycle checkpoint arrest, a...
Autores principales: | Gabrielli, Brian, Brooks, Kelly, Pavey, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270485/ https://www.ncbi.nlm.nih.gov/pubmed/22347187 http://dx.doi.org/10.3389/fphar.2012.00009 |
Ejemplares similares
-
Molecular Targeted Agent and Immune Checkpoint Inhibitor Co-Loaded Thermosensitive Hydrogel for Synergistic Therapy of Rectal Cancer
por: Zhang, Huaiyu, et al.
Publicado: (2021) -
Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager
por: Anbari, Samira, et al.
Publicado: (2023) -
Drug therapy for myocarditis induced by immune checkpoint inhibitors
por: Wu, Yihao, et al.
Publicado: (2023) -
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
por: Tamburrino, Anna, et al.
Publicado: (2013) -
Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
por: Cui, Yuting, et al.
Publicado: (2022)